Purple Biotech Income Statement (2014-2025) | PPBT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating items
Depreciation & Amortization - Total (Quarter)	0.05M	0.06M	0.06M	0.06M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.04M	0.04M	0.05M	0.06M	0.05M
Research & Development (Quarter)	4.87M	2.09M	1.62M	3.25M	5.95M	2.08M	3.46M	4.82M	3.50M	3.71M	4.59M	5.24M	3.42M	2.39M	1.35M	0.46M	0.76M	0.55M	0.59M	1.83M
Share-based Compensation (IS) (Quarter)	0.71M	0.68M	0.39M	0.30M	0.31M	0.56M	0.71M	0.84M	0.75M	0.49M	0.45M	0.18M	0.27M	0.22M	0.13M	-0.34M	0.09M	0.06M	0.20M	-0.24M
Selling, General & Administrative (Quarter)	1.66M	1.53M	1.42M	1.49M	1.38M	1.51M	1.62M	1.78M	1.62M	1.43M	1.16M	1.02M	1.04M	0.86M	0.79M	0.56M	0.65M	0.68M	0.78M	1.14M
Other Operating Expenses (Quarter)	0.09M	-0.06M	0.09M	2.98M		-0.05M
Operating Expenses (Quarter)	6.67M	3.62M	3.20M	7.78M	7.38M	3.59M	5.13M	6.65M	5.17M	5.19M	5.80M	6.32M	4.51M	3.31M	2.18M	1.06M	1.45M	1.28M	1.43M	3.02M
Operating Income (Quarter)	6.53M	3.62M	3.04M	4.74M	7.33M	3.59M	5.08M	6.60M	5.12M	5.13M	5.75M	6.27M	4.47M	3.46M	2.13M	1.02M	1.41M	1.24M	1.37M	23.45M
EBIT (Quarter)	6.53M	3.62M	3.04M	4.74M	7.33M	3.59M	5.08M	6.60M	5.12M	5.13M	5.75M	6.27M	4.47M	3.46M	2.13M	1.02M	1.41M	1.24M	1.37M	23.45M
Non-operating items
Non Operating Investment Income (Quarter)												-3.50M
Interest & Investment Income (Quarter)	-0.12M	-0.08M	-0.07M	-0.06M	-0.06M	-0.09M	-0.25M	-0.58M	-0.28M	-0.12M	-0.71M	2.10M	-0.10M	-0.12M	-0.13M	-0.46M	-0.05M	-0.07M	-0.12M	-0.08M
Other Non Operating Income (Quarter)												-3.50M		-0.95M	-1.85M	-0.08M				0.06M
Non Operating Income (Quarter)	-0.10M	0.02M	-0.05M	0.01M	-0.01M	-0.04M	-0.23M	-0.56M	-0.22M		-0.69M	-1.41M	-0.69M		-1.47M	-0.60M	-0.95M		-0.06M	0.20M
Net income details
EBT (Quarter)	6.39M	3.44M	2.95M	4.61M	7.23M	3.45M	4.82M	6.01M	4.79M	4.86M	5.02M	6.28M	4.35M	3.31M	1.49M	0.63M	1.32M	1.18M	1.24M	23.15M
Profit After Tax (Quarter)	6.43M	3.64M	3.15M	5.11M	-7.32M	3.55M	4.85M	6.04M	4.90M	5.16M	5.05M	4.86M	-3.78M	2.42M	0.67M	0.41M	-0.46M	1.09M	1.30M	23.64M
Income from Non-Controlling Interests (Quarter)	0.02M	0.33M	0.31M	0.03M	0.02M	0.02M	0.03M	0.03M	0.03M	0.02M	0.12M	0.03M	0.07M	0.06M	0.06M	0.01M	0.05M	0.04M	0.04M	0.10M
Income from Continuing Operations (Quarter)	6.39M	3.44M	2.95M	4.61M	7.23M	3.45M	4.82M	6.01M	4.79M	4.86M	5.02M	6.28M	4.35M	3.31M	1.49M	0.63M	1.32M	1.18M	1.24M	23.15M
Consolidated Net Income (Quarter)	0.14M	-0.00M	0.15M	0.35M	7.23M	3.45M	4.82M	6.01M	4.79M	4.86M	5.02M	6.28M	4.35M	3.31M	1.49M	0.63M	1.32M	1.18M	1.24M	23.15M
Income towards Parent Company (Quarter)	6.55M	3.63M	3.14M	5.07M	7.30M	3.56M	4.82M	6.01M	4.88M	5.14M	5.04M	4.83M	3.78M	2.41M	0.66M	0.41M	0.45M	1.08M	1.30M	23.55M
Net Income towards Common Stockholders (Quarter)	6.55M	3.63M	3.14M	5.07M	7.30M	3.56M	4.82M	6.01M	4.88M	5.14M	5.04M	4.83M	3.78M	2.41M	0.66M	0.41M	0.45M	1.08M	1.30M	23.55M
Additional items
EPS (Basic) (Quarter)				0.29				6.65				4.36		0.10M	0.03M	0.00		0.36M	0.33M	0.02
EPS (Weighted Average and Diluted) (Quarter)								6.65				4.36				0.25				49.05
Shares Outstanding (Weighted Average) (Quarter)				17.57M				0.90M				1.11M		23.00	23.00	1,000.00M		3.00	4.00	960.11M
Shares Outstanding (Diluted Average) (Quarter)								0.90M				1.11M				1.64M				0.48M
EBITDA (Quarter)	6.58M	3.68M	3.10M	4.80M	7.38M	3.64M	5.13M	6.65M	5.17M	5.19M	5.80M	6.32M	4.51M	3.51M	2.18M	1.06M	1.45M	1.28M	1.43M	23.50M
Interest Expenses (Quarter)	0.02M	0.10M	0.02M	0.07M	0.04M	0.05M	0.02M	0.02M	0.06M	0.15M	0.02M	2.09M	0.02M	0.02M	0.51M	-0.07M	0.04M	-0.02M	0.01M	0.21M

Research Tools

Purple Biotech Income Statement (2014-2025) | PPBT

Create an account

Sign In

Reset Password